Real-time enrollment status for this huntington disease clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT07378644 |
| Recruiting Status | Recruiting |
| Condition | Huntington Disease |
| Phase | PHASE2 |
| Target Enrollment | 400 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Skyhawk Therapeutics, Inc. |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 16, 2026: Clinical trial NCT07378644 is currently recruiting participants. This phase2 study for huntington disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Skyhawk Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07378644 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07378644 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.